Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Innovation in the cath lab: Cardiologists develop, perform new interventional heart procedure

Interventional cardiologists in Detroit developed the new technique with a specific patient in mind. One specialist described it as an "exciting breakthrough."

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

Thumbnail

AFib ablation in young adults linked to improved quality of life, new Cleveland Clinic study confirms

“These and other data support that young adults do as well as a more traditional patient population when looking at arrhythmia-free survival,” researchers wrote.

Mitral Valve Surgery from the University of Washington

Cardiologists make history, removing device and implanting new valve in first heart procedure of its kind

“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said. 

An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. This software is still undergoing beta testing at several hospitals and will likely be rolled out commercially later in 2023.

Cardiology has embraced AI more than most other specialties

Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing. 

Data on a next-generation balloon-expandable transcatheter heart valve

Next-gen TAVR valve, tested on patients for very first time, linked to high success rate

A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required. 

Thumbnail

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, discusses how artificial intelligence (AI) is impacting cardiac imaging.

What is the ROI for adopting AI in cardiac imaging?

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.